Clinilabs Drug development Corporation

New York, New York NY10019

1 studies enrolling now · 8 studies all time

What they study most

Alzheimer Disease, Cataplexy, Excessive Daytime Sleepiness, Healthy Volunteers, Insomnia, Major Depressive Disorder, Narcolepsy, Obstructive Sleep Apnea, Transient Insomnia

Studies at this site

• ANC-501 in the Treatment of Adults With Major Depressive Disorder — Completed
• Safety, Tolerability and Efficacy Study of V117957 in Subjects With Insomnia Associated With Alcohol Cessation — Completed
• Trial of AD036 in Obstructive Sleep Apnea — Completed
• Once-Nightly Sodium Oxybate for Treatment of Excessive Daytime Sleepiness and Cataplexy in Narcolepsy — Completed
• Study to Evaluate the Effect of CT1812 Treatment on Amyloid Beta Oligomer Displacement Into CSF in Subjects With Mild to Moderate Alzheimer's Disease — Completed
• A Study to Evaluate Next-Dose Transition From Zolpidem to Lemborexant (LEM) for the Treatment of Insomnia — Completed
• A Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics (PK) of Oral TAK-994 in an Acute Sleep Phase Delay Paradigm in Healthy Male Participants — Completed
• SM-1 vs. an Active Comparator in A Model of Transient Insomnia — Starting soon